A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States
Poghosyan H, Sarkar S, Richman I, Pietrzak R, Carter-Bawa L, Cooley M. A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States. JTO Clinical And Research Reports 2024, 5: 100705. PMID: 39282662, PMCID: PMC11402037, DOI: 10.1016/j.jtocrr.2024.100705.Peer-Reviewed Original ResearchLung cancer screeningLung cancer screening utilizationScreening utilizationBehavioral Risk Factor Surveillance SystemRates of lung cancer screeningRisk Factor Surveillance SystemScreening-eligible individualsCancer screening utilizationLung cancer burdenPopulation-based dataMultivariate logistic regressionCancer screeningCancer burdenImpact healthcareNational ratesIncreased oddsLogistic regressionNationwide effortSurveillance systemCOVID-19COVID-19 pandemicLung diseaseBrief reportNo sex differencesUnited StatesLung cancer screening use among screening‐eligible adults with disabilities
Poghosyan H, Richman I, Sarkar S, Presley C. Lung cancer screening use among screening‐eligible adults with disabilities. Journal Of The American Geriatrics Society 2024, 72: 1155-1165. PMID: 38357789, PMCID: PMC11018473, DOI: 10.1111/jgs.18795.Peer-Reviewed Original ResearchLung cancer screeningDisability countSelf-careDisability typeHarms of lung cancer screeningUS Preventive Services Task Force criteriaLung Cancer Screening ModuleLung cancer screening utilizationBehavioral Risk Factor Surveillance SystemRates of lung cancer screeningRisk Factor Surveillance SystemCancer screening useScreening-eligible adultsIndependent livingLack of clinical guidelinesTobacco use historyCognitive impairmentTask Force criteriaCross-sectional dataCancer screeningMultivariate logistic regression analysisLogistic regression analysisScreen useNo cognitive impairmentPack-years